2025-03-12 12:59:11
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Windlas Biotech Ltd reports Rs. 12.19 crores consolidated PAT in Q2 FY2023
Posted On : 2022-11-08 20:18:46( TIMEZONE : IST )
Windlas Biotech Ltd has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 135.341 crores during the period ended September 30, 2022 as compared to Rs. 122.794 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. 12.194 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 9.80 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. 5.59 for the period ended September 30, 2022 as compared to Rs. 4.50 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 135.341 crs | ₹122.794 crs |  10.22% |
| Net Profit | ₹12.194 crs | ₹9.80 crs | 24.43% |
| EPS | ₹5.59 | ₹4.50 | 24.22% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 135.341 crores during the period ended September 30, 2022 as compared to Rs.116.471 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.12.194 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.8.30 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.5.59 for the period ended September 30, 2022 as compared to Rs.4.10 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 135.341 crs | ₹116.471 crs | 16.20% |
| Net Profit | ₹12.194 crs | ₹8.30 crs | 46.92% |
| EPS | ₹5.59 | ₹4.10 | 36.34% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.258.135 crores during the 6 Months period ended September 30, 2022 as compared to Rs.228.116 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.21.994 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.14.987 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.10.09 for the 6 Months period ended September 30, 2022 as compared to Rs.7.79 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹258.135 crs | ₹228.116 crs | 13.16% |
| Net Profit | ₹21.994 crs | ₹14.987 crs | 46.75% |
| EPS | ₹10.09 | ₹7.79 | 29.53% |
Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 253.55 as compared to the previous close of Rs. 242.70. The total number of shares traded during the day was 5790 in over 396 trades.
The stock hit an intraday high of Rs. 255.00 and intraday low of 245.90. The net turnover during the day was Rs. 1459475.00.
